2m 2m 2m 2m 2m 2m 2m
APREA THERAPEUT (APRE)
NASDAQ
$0.83+$0.04 (+4.71%)
Price as of Jun 23, 2026 7:44 PM EDT- $9.8MMarket Cap
- -50.40%1-Year Change
- BiotechnologyIndustry
APREA THERAPEUT (APRE)
$0.83+$0.04 (+4.71%)
APRE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.79 | ||
Change | +$0.08 (+10.99%) | ||
Open | $0.81 | ||
High | $0.84 | ||
Low | $0.72 | ||
Previous Close | $0.71 | ||
Volume | 373,164 | ||
30-Day Average Volume | 128,626 | ||
1-Week Change | 13.60% | ||
1-Month Change | -16.46% | ||
1-Year Change | -50.40% | ||
3-Year Change | -75.12% | ||
5-Year Change | -99.15% | ||
Fundamentals | |||
Shares Outstanding | 12.4M | ||
Total Assets | $47.6M | ||
Market Cap | $9.8M | ||
Enterprise Value | -$36.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.3M | ||
Free Cash Flow | -$2.8M | ||
EBIT | -$3.3M | ||
EBITDA | -$3.3M | ||
Net Working Capital | $41.9M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | 11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 02/13/2023 | ||
Earnings & Revenue